Researchers from Heidelberg Pharma AG have presented a new antibody-drug conjugate (ADC) that shows promise for treating pancreatic ductal adenocarcinoma (PDAC). The ADC, called hRS7 ATAC, targets ...

Fredrick Rosario-Joseph and colleagues created a line of mice in which the trophoblast-;the main cell type in the placenta ...